Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-12-22

FDA Approved: PLEGRIDY PEN — Supplemental Application (Biogen Inc.)

View source ↗

Summary

The FDA approved a supplemental application for the PLEGRIDY PEN auto-injector to administer peginterferon beta-1a (Plegridy) for multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PLEGRIDY PEN (Peginterferon beta-1a)

Snippet

SUPPL AP for PLEGRIDY PEN (PEGINTERFERON BETA-1A)